These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 115034)

  • 1. Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine.
    Buus Lassen J; Lund J; Bechgaard E; Søndergaard I
    Psychopharmacology (Berl); 1979 Aug; 64(2):149-53. PubMed ID: 115034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
    Lassen JB; Lund J; Søndergaard I
    Psychopharmacology (Berl); 1980; 68(3):229-33. PubMed ID: 6446724
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of nialamide-induced hypermotility in mice by lithium and the 5-HT uptake inhibitors chlorimipramine and FG 4963.
    Lassen JB; Squires RF
    Neuropharmacology; 1976 Nov; 15(11):665-8. PubMed ID: 137365
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of both MAO-A and MAO-B required for the production of hypermotility in mice with the 5HT uptake inhibitors chlorimipramine and femoxetine.
    Lasen JB; Squires RF
    Neuropharmacology; 1977; 16(7-8):485-8. PubMed ID: 562482
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of whole blood serotonin in depressed patients treated with a new, selective serotonin-uptake inhibitor, femoxetine.
    Børup C; Petersen IM; le Fèvre Honoré P; Wetterberg L
    Psychopharmacology (Berl); 1979 Jun; 63(3):241-3. PubMed ID: 113809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.
    Ortiz J; Artigas F
    Br J Pharmacol; 1992 Apr; 105(4):941-6. PubMed ID: 1387022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nialamide-induced hypermotility in mice treated with inhibitors of monoamine uptake, 5-HT antagonists and lithium.
    Buus Lassen J
    Psychopharmacology (Berl); 1989; 98(2):257-61. PubMed ID: 2526956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of desipramine and the 5-HT uptake inhibitors femoxetine and paroxetine with the acute hypotensive effect of guanethidine in conscious spontaneously hypertensive rats.
    Petersen EN
    J Pharm Pharmacol; 1979 Sep; 31(9):638-40. PubMed ID: 41071
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
    Sugrue MF
    Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the new 5-HT-uptake inhibitor paroxetine on hypermotility in rats produced by p-chloroamphetamine (PCA) and 4,alpha-dimethyl-7-tyramine (H 77/77).
    Lassen JB
    Psychopharmacology (Berl); 1978 Apr; 57(2):151-3. PubMed ID: 418448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT antagonism on cerebral and common carotid arteries by the 5-HT uptake inhibitors femoxetine and paroxetine.
    Petersen EN; Edvinsson L; Hardebo JE
    Acta Pharmacol Toxicol (Copenh); 1979 Oct; 45(4):296-301. PubMed ID: 525361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram.
    Pawłowski L; Nowak G
    J Pharm Pharmacol; 1987 Dec; 39(12):1003-9. PubMed ID: 2894425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5HT uptake inhibitors on the pressor response to 5HT in the pithed rat. The significance of the 5HT blocking property.
    Petersen EN; Olsson SO; Squires RF
    Eur J Pharmacol; 1977 Jun; 43(3):209-15. PubMed ID: 872876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and release of 5-hydroxytryptamine by enteric 5-hydroxytryptaminergic neurones: effects of fluoxetine (Lilly 110140) and chlorimipramine.
    Gershon MD; Jonakait GM
    Br J Pharmacol; 1979 May; 66(1):7-9. PubMed ID: 313230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats.
    Pawłowski L
    J Pharm Pharmacol; 1984 Mar; 36(3):197-9. PubMed ID: 6144758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of the selective 5-HT uptake inhibitor WY 27587 on 5-HT uptake into platelets and synaptosomes in the rat.
    Billingsley AJ; Brammer NT; Wood MD; Minchin MC
    Neuropharmacology; 1989 Jan; 28(1):33-6. PubMed ID: 2522598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in human platelet 5 HT level after 1 week of chlorimipramine treatment.
    Poirier MF; Le Quan-Bui KH; Lôo H; Meyer P
    Psychopharmacology (Berl); 1985; 86(1-2):194-6. PubMed ID: 3927355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in platelet function and blood serotonin level in migraine patients during treatment with femoxetine.
    Dalsgaard-Nielsen J; le Fèvre Honoré P; Zeeberg I
    Acta Neurol Scand; 1982 Aug; 66(2):191-8. PubMed ID: 6982585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.